Paliperidone is a dopamine antagonist and 5-HT2A antagonist of the atypical antipsychotic class of medications. It is developed by Janssen Pharmaceutica. Invega is an extended release formulation of paliperidone that uses the OROS extended release system to allow for once-daily dosing.Paliperidone has antagonist effect at α1 and α2 adrenergic receptors and at H1 histamine receptors. It does not bind to muscarinic acetylcholine receptors. In addition, it binds with dopamine and serotonin receptors.
Dopamine Receptor Inhibitors Related Products:
Ropinirole hydrochloride; Quetiapine fumarate; Domperidone; Amisulpride; ONC206; Sulpiride; SKF-38393 HCl